Marcel P M Stokkel

9PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologiesInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2024
The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy.

Jetske L B Gunster, Frederieke H van Duijnhoven, Astrid N Scholten

|Jun 12, 2024
Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer.

Josefien P van Olmen, A Marjolein Schrijver, Marcel P M Stokkel

|Jan 04, 2023
The effect of long-acting somatostatin analogues on the uptake of [177Lu]Lu-HA-DOTATATE.

Chayenne H A M Veerman, Hinke Siebinga, Daphne M V de Vries-Huizing

|Dec 14, 2022
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough.

Hinke Siebinga, Chayenne H A M Veerman, Linda de Wit-van der Veen

|Oct 30, 2020
Day-to-day variability of [68Ga]Ga-PSMA-11 accumulation in primary prostate cancer: effects on tracer uptake and visual interpretation.

Judith Olde Heuvel, Berlinda J de Wit-van der Veen, Maarten L Donswijk

|Aug 13, 2020
The use of FDG-PET/CT to detect early recurrence after resection of high-risk stage III melanoma.

Emma H A Stahlie, Bernies van der Hiel, Marcel P M Stokkel

Pageof 2

Frequent Collaborators

2 joint publications

Claudette E Loo

2 joint publications

Frederieke H van Duijnhoven

2 joint publications

A Marjolein Schrijver

2 joint publications

Jetske L B Gunster